ROTHBLATT MARTINE A
Reporting owner on Forms 3, 4 and 5, CIK 1106578.
ROTHBLATT MARTINE A reported on 1 issuer in 8 filings, the latest a Form 4 filed 2026-10-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| UNITED THERAPEUTICS Corp CIK 1082554 | director, officer (Chairperson & CEO) | 8 | 2026-10-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | M exercised | +9,500 | $117.76 | 333,943 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -700 | $542.0614 | 333,243 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -408 | $542.8734 | 332,835 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -1,032 | $544.1749 | 331,803 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -1,280 | $544.8996 | 330,523 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -309 | $546.7466 | 330,214 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -1,171 | $547.9926 | 329,043 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -1,206 | $548.8749 | 327,837 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -757 | $549.5911 | 327,080 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -432 | $550.9887 | 326,648 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -725 | $551.8169 | 325,923 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -160 | $552.8563 | 325,763 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -80 | $554.3 | 325,683 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -80 | $555.6043 | 325,603 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -240 | $557.4315 | 325,363 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -120 | $558.5967 | 325,243 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -120 | $560.66 | 325,123 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -40 | $562.35 | 325,083 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -80 | $563.88 | 325,003 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -80 | $566.58 | 324,923 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -240 | $569.8973 | 324,683 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -120 | $570.6969 | 324,563 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -80 | $572.4369 | 324,483 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-02 | S sold | -40 | $574.225 | 324,443 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock, holding | 40,513 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 166 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 249,108 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 45,596 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 8,902 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Stock Option, derivative | 2026-10-02 | M exercised | -9,500 | $0 | 309,410 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | M exercised | +9,500 | $117.76 | 333,943 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -120 | $560.05 | 333,823 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -80 | $561.68 | 333,743 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -160 | $563.31 | 333,583 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -94 | $567.9028 | 333,489 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -306 | $569.6523 | 333,183 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -534 | $570.5495 | 332,649 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -320 | $571.5238 | 332,329 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -560 | $572.8626 | 331,769 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -280 | $573.6243 | 331,489 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -830 | $574.944 | 330,659 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -1,346 | $575.9027 | 329,313 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -774 | $576.9053 | 328,539 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -930 | $577.9324 | 327,609 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -320 | $579.02 | 327,289 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -864 | $580.1984 | 326,425 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -702 | $581.2134 | 325,723 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -520 | $582.2412 | 325,203 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -400 | $583.2831 | 324,803 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -360 | $584.6622 | 324,443 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock, holding | 40,513 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 166 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 249,108 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 45,596 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 8,902 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Stock Option, derivative | 2026-10-01 | M exercised | -9,500 | $0 | 318,910 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -400 | $547.294 | 325,963 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -280 | $548.2529 | 325,683 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -240 | $549.3977 | 325,443 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -400 | $550.4675 | 325,043 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -160 | $551.495 | 324,883 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -120 | $552.6267 | 324,763 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -113 | $553.7787 | 324,650 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -207 | $554.6997 | 324,443 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock, holding | 40,513 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 166 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 249,108 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 45,596 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 8,902 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | M exercised | +9,500 | $117.76 | 333,943 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -161 | $476.1417 | 333,782 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -749 | $477.4259 | 333,033 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -650 | $478.4676 | 332,383 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -359 | $479.6683 | 332,024 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -601 | $480.7942 | 331,423 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -160 | $482.3575 | 331,263 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -80 | $487.79 | 331,183 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -40 | $495.32 | 331,143 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -40 | $511.37 | 331,103 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -80 | $514.9 | 331,023 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -80 | $517.165 | 330,943 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -80 | $523.36 | 330,863 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -80 | $524.62 | 330,783 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -80 | $526.09 | 330,703 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -160 | $531.11 | 330,543 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -160 | $536.52 | 330,383 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -200 | $537.67 | 330,183 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -40 | $538.65 | 330,143 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -480 | $540.7775 | 329,663 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -580 | $541.7616 | 329,083 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -600 | $543.245 | 328,483 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -840 | $544.048 | 327,643 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -920 | $545.129 | 326,723 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-30 | S sold | -360 | $546.2322 | 326,363 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock, holding | 40,513 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 166 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 249,108 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 45,596 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 8,902 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Stock Option, derivative | 2026-09-30 | M exercised | -9,500 | $0 | 328,410 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-29 | M exercised | +9,500 | $117.76 | 333,943 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-29 | S sold | -400 | $472.0452 | 333,543 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-29 | S sold | -449 | $472.9682 | 333,094 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-29 | S sold | -80 | $473.8553 | 333,014 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-29 | S sold | -552 | $475.115 | 332,462 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-29 | S sold | -1,395 | $476.1005 | 331,067 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-29 | S sold | -2,135 | $477.087 | 328,932 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-29 | S sold | -2,309 | $478.0956 | 326,623 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-29 | S sold | -1,200 | $479.0745 | 325,423 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-29 | S sold | -160 | $479.59 | 325,263 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-29 | S sold | -500 | $481.2241 | 324,763 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-29 | S sold | -120 | $482.2806 | 324,643 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-29 | S sold | -200 | $486.77 | 324,443 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock, holding | 40,513 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 166 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 249,108 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 45,596 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 8,902 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Stock Option, derivative | 2026-09-29 | M exercised | -9,500 | $0 | 337,910 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | M exercised | +9,500 | $117.76 | 333,943 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -280 | $472.4274 | 333,663 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -600 | $473.2762 | 333,063 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -680 | $474.4551 | 332,383 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -80 | $475.28 | 332,303 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -160 | $476.675 | 332,143 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -200 | $477.448 | 331,943 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -601 | $479.0571 | 331,342 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -1,013 | $480.1843 | 330,329 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -1,354 | $481.1977 | 328,975 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -693 | $482.1125 | 328,282 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -1,539 | $483.202 | 326,743 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -825 | $484.4661 | 325,918 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -1,315 | $485.4544 | 324,603 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-28 | S sold | -160 | $486.005 | 324,443 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock, holding | 166 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 40,513 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 249,108 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 45,596 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 8,902 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Stock Option, derivative | 2026-09-28 | M exercised | -9,500 | $0 | 347,410 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-25 | M exercised | +9,500 | $117.76 | 333,943 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-25 | S sold | -40 | $470.5565 | 333,903 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-25 | S sold | -200 | $471.8378 | 333,703 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-25 | S sold | -800 | $472.886 | 332,903 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-25 | S sold | -543 | $474.1472 | 332,360 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-25 | S sold | -1,613 | $475.2775 | 330,747 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-25 | S sold | -2,744 | $476.1324 | 328,003 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-25 | S sold | -1,280 | $477.1915 | 326,723 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-25 | S sold | -1,648 | $478.1807 | 325,075 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-25 | S sold | -632 | $478.9522 | 324,443 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock, holding | 40,513 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 166 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 249,108 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 45,596 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 8,902 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Stock Option, derivative | 2026-09-25 | M exercised | -9,500 | $0 | 356,910 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-24 | M exercised | +9,500 | $117.76 | 333,943 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-24 | S sold | -640 | $469.7352 | 333,303 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-24 | S sold | -2,603 | $470.628 | 330,700 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-24 | S sold | -2,160 | $471.7714 | 328,540 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-24 | S sold | -580 | $472.7308 | 327,960 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-24 | S sold | -437 | $474.0059 | 327,523 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-24 | S sold | -320 | $475.3547 | 327,203 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-24 | S sold | -280 | $476.5133 | 326,923 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-24 | S sold | -360 | $477.5825 | 326,563 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-24 | S sold | -1,480 | $478.6058 | 325,083 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-24 | S sold | -600 | $479.5167 | 324,483 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-09-24 | S sold | -40 | $480.33 | 324,443 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock, holding | 40,513 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 166 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 249,108 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 45,596 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Common Stock, holding | 8,902 | Form 4 | ||||
| UNITED THERAPEUTICS Corp Stock Option, derivative | 2026-09-24 | M exercised | -9,500 | $0 | 366,410 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001106578-26-000156 | UNITED THERAPEUTICS Corp | 2026-10-05 | ||
| Form 4 0001106578-26-000155 | UNITED THERAPEUTICS Corp | 2026-10-02 | ||
| Form 4 0001106578-26-000154 | UNITED THERAPEUTICS Corp | 2026-10-01 | ||
| Form 4 0001106578-26-000153 | UNITED THERAPEUTICS Corp | 2026-10-01 | ||
| Form 4 0001106578-26-000152 | UNITED THERAPEUTICS Corp | 2026-09-30 | ||
| Form 4 0001106578-26-000151 | UNITED THERAPEUTICS Corp | 2026-09-29 | ||
| Form 4 0001106578-26-000150 | UNITED THERAPEUTICS Corp | 2026-09-28 | ||
| Form 4 0001106578-26-000149 | UNITED THERAPEUTICS Corp | 2026-09-25 |